50 related articles for article (PubMed ID: 10371846)
1. [Experimental anatomo-pathologic study in the myocardium of animals with arterial hypertension caused via a nitric oxide synthesis blocker].
Xavier-Vidal R; Madi K; de Lima RJ; Marques NM; Reis Ade A; Paes Lda S
Rev Port Cardiol; 1999 Apr; 18(4):381-91. PubMed ID: 10371846
[TBL] [Abstract][Full Text] [Related]
2. [The stereology of the myocardium in rats hypertensive due to the use of an inhibitor of nitric oxide synthesis].
Pereira LM; Mandarim-de-Lacerda CA
Rev Port Cardiol; 1997 Oct; 16(10):753-9, 743. PubMed ID: 9479938
[TBL] [Abstract][Full Text] [Related]
3. Oxytalan elastic and collagen fibers during the repair process in experimental nitric oxide inhibition.
Xavier-Vidal R
Clinics (Sao Paulo); 2005 Apr; 60(2):85-92. PubMed ID: 15880243
[TBL] [Abstract][Full Text] [Related]
4. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
[TBL] [Abstract][Full Text] [Related]
5. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
6. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
7. Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats.
Zicha J; Pechánová O; Dobesová Z; Kunes J
Clin Sci (Lond); 2003 Oct; 105(4):483-9. PubMed ID: 12816535
[TBL] [Abstract][Full Text] [Related]
8. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H
Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445
[TBL] [Abstract][Full Text] [Related]
9. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
11. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Bernátová I; Pechánová O; Pelouch V; Simko F
J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
[TBL] [Abstract][Full Text] [Related]
12. Hypertensive effects of oral administration of the aqueous extract of Solanum torvum fruits in L-NAME treated rats: evidence from in vivo and in vitro studies.
Nguelefack TB; Mekhfi H; Dongmo AB; Dimo T; Watcho P; Zoheir J; Legssyer A; Kamanyi A; Ziyyat A
J Ethnopharmacol; 2009 Jul; 124(3):592-9. PubMed ID: 19439171
[TBL] [Abstract][Full Text] [Related]
13. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
Bernátová I; Pechánová O; Simko F
Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats.
Zanfolin M; Faro R; Araujo EG; Guaraldo AM; Antunes E; De Nucci G
J Cardiovasc Pharmacol; 2006 Mar; 47(3):391-5. PubMed ID: 16633081
[TBL] [Abstract][Full Text] [Related]
16. Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
Pechánová O; Bernátová I; Babál P
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():6-9. PubMed ID: 10707823
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibition in rats: melatonin reduces blood pressure and ischemia/reperfusion-induced infarct size.
Deniz E; Sahna E; Aksulu HE
Scand Cardiovasc J; 2006 Aug; 40(4):248-52. PubMed ID: 16914418
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of prior physical conditioning on relaxing response of corpus cavernosum from rats made hypertensive by nitric oxide inhibition.
Claudino MA; Priviero FB; Camargo EA; Teixeira CE; De Nucci G; Antunes E; Zanesco A
Int J Impot Res; 2007; 19(2):189-95. PubMed ID: 16915305
[TBL] [Abstract][Full Text] [Related]
19. Is there a link between salt-intake and atrial natriuretic peptide system during hypertension induced by nitric oxide blockade?
Marchi Alves LM; Tosi LR; Antunes-Rodrigues J; Cárnio EC
Regul Pept; 2004 Aug; 120(1-3):127-32. PubMed ID: 15177930
[TBL] [Abstract][Full Text] [Related]
20. In vivo protein synthetic rates of atrial, ventricular, and pulmonary tissue proteins in aortic constriction, goldblatt, and bromoethylamine models of hypertension.
Siddiq T; Patel VB; Sherwood R; Richardson PJ; Preedy VR
Exp Mol Pathol; 2001 Feb; 70(1):19-30. PubMed ID: 11170787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
